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Abstract
Background: The ideal identification of Staphylococcus aureus clinical isolates requires a battery of tests and this is
costly in resource limited settings. In many developing countries, the tube coagulase test is usually confirmatory for
S. aureus and is routinely done using either human or sheep plasma. This study evaluated Mannitol salt agar and
the deoxyribonuclease (DNase) test for improving the efficiency of the tube coagulase test in resource limited
settings. The efficiency of human and sheep plasma with tube coagulase tests was also evaluated.
Methods: One hundred and eighty Gram positive, Catalase positive cocci occurring in pairs, short chains or
clusters were subjected to growth on Mannitol salt agar, deoxyribonuclease and tube coagulase tests. Of these,
isolates that were positive for at least two of the three tests (n = 60) were used to evaluate the performance of
the tube coagulase test for identification of S. aureus, using PCR-amplification of the nuc gene as a gold standard.
Results: Human plasma was more sensitive than sheep plasma for the tube coagulase test (sensitivity of 91% vs.
81% respectively), but both plasmas had very low specificity (11% and 7% respectively). The sensitivity and
specificity of the tube coagulase test (human plasma) was markedly improved when Mannitol salt agar and DNase
were introduced as a tri-combination test for routine identification of Staphylococcus aureus (100% specificity and
75% sensitivity). The specificity and sensitivity of Mannitol salt agar/DNase/tube coagulase (sheep plasma)
combination was 100% and 67%, respectively.
Conclusion: The efficiency of the tube coagulase test can be markedly improved by sequel testing of the isolates
with Mannitol salt agar, DNase and Tube coagulase. There is no single phenotypic test (including tube coagulase)
that can guarantee reliable results in the identification of Staphylococcus aureus.
Background
Staphylococcus aureus is a ubiquitous commensal bac-
terium on human skins and anterior nares, but fre-
quently causes severe infections in humans [1]. Rapid
and direct identification of S. aureus is crucial for
proper management of patients with skin infections,
abscesses, septicemia/bacteremia, gastroenteritis, endo-
carditis, toxic shock syndrome and certain food intoxi-
cations [2,3]. In developing countries, phenotypic tests
are the mainstay in the diagnosis of staphylococcal
infections, in which coagulase tests are usually confirma-
tory for S. aureus [4-8]. Coagulase testing is performed
using the slide coagulase (SCT) or the tube coagulase
(TCT) methods [9]. Although these tests efficiently
identify S. aureus, their performances vary from setting
to setting and need improvement [3,6].
Several laboratories in developing countries screen for
presumptive Staphylococcus aureus based on growth on
Mannitol salt agar (MSA) and/or DNase tests and confir-
mation is done with the TCT. In many settings, the use
of the TCT is curtailed by reliance on human plasma,
since the recommended plasmas (from rabbit, horse [10])
are either expensive or if locally available, are of poor
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results [6]; usually obtained from blood banks as outdated
materials, it contains variable amounts of CRF (Coagu-
lase-Reacting Factor) and anti-staphylococcal antibodies
[9]. This type of plasma is not recommended for coagu-
lase tests [9]. Other factors which make human plasma
inappropriate for the coagulase tests include; a high bur-
den of viral infections (such as HIV/AIDS, Hepatitis B
and C) in resource limited settings that can render the
plasma risky to laboratory workers and prior to use, it
must be screened for safety. There are also ethical issues
accompanying the use of human specimens. Conversely,
the efficiency of other plasmas in many laboratory set-
tings varies and has to be determined for proper identifi-
cation of S. aureus with coagulase tests.
Although coagulase tests are invaluable for identification
of Staphylococcus aureus, few studies have evaluated their
use in routine practice [10]. In addition, diagnostic labora-
tories are occasionally faced with organisms with biochem-
ical characteristics that do not fit into the patterns of a
known genus and species [11]. Furthermore, there are
some problems associated with coagulase tests; firstly,
some human CoNS (Coagulase Negative Staphylococci)
produce clumping factor and may be falsely positive with
the SCT [9,12]. Secondly, some staphylococci of animal
origin are clumping factor negative and tube coagulase
positive; these may be misidentified as S. aureus,u n l e s s
the fermentation of Mannitol is utilized in addition [9].
Whereas Mannitol salt agar was developed for the pre-
sumptive isolation of S. aureus in a single step, which is
convenient for diagnostic laboratories, Mannitol positive
CoNS have been reported in nasal and clinical specimens
from Nigeria and Japan [13,14]. Furthermore, Mannitol
negative MRSA (Methicilin Resistant Staphylococcus aur-
eus) was reported from clinical specimens in Kwazulu
Natal province, South Africa [15]. In view of the above,
the common identification methods for S. aureus were
evaluated, aiming at improving the diagnosis of S. aureus
through a combination of available phenotypic methods.
This study reveals that there is no single test (includ-
ing the tube coagulase test) that can guarantee reliable
results for the identification of S. aureus. However,
improved diagnostic sensitivity and specificity of the
tube coagulase test were achieved upon simultaneous
testing of the isolates with DNase and Mannital salt
agar. In order to improve the identification of S. aureus
in resource limited settings, sequel testing of the isolates
with Mannitol salt agar, tube DNase and coagulase is
proposed.
Methods
Study setting
This study was done in the Clinical Microbiology and
Molecular Biology laboratories of the Department of
Medical Microbiology, Makerere University College of
Health Sciences, from January through June, 2009. It
was a laboratory based study that involved frozen clini-
cal isolates from patients’ blood, cerebral spinal fluid,
anterior nares, skin and wound swabs.
Inclusion/exclusion criteria
One hundred and eighty Gram positive, Catalase posi-
tive cocci occurring in pairs, short chains or clusters
were subjected to growth on MSA, tube coagulase and
DNase tests (see below). Of these (N = 180), isolates
that were positive for at least two of the three tests
(n = 60) were used to evaluate the performance of the
tube coagulase test for identification of S. aureus,u s i n g
PCR-amplification of the nuc gene (which is specific for
S. aureus) as the gold standard.
Phenotypic identification of Staphylococcus aureus
Isolates were incubated at 37°C for 24 hours on blood
agar and then sub-cultured on TS (Tryptic Soya, Liofil-
chem, Italy) agar (Fisher, Leicestershire, UK). Single
colonies were tested with tube coagulase and DNase test
a n dg r o w t ho nM S A .T oe v a l u a t et h ep e r f o r m a n c eo f
the individual tests or a combination of tests, sequel
testing of the isolates was done beginning with MSA,
followed by DNase and TCT.
To confirm fermentation of mannitol, growth of yel-
low colonies on MSA (Oxoid, Cambridge, UK) sur-
rounded by yellow zones after 24 hours of incubation at
37°C indicated a positive result. DNase test was per-
formed by incubating the isolates for 24 hours at 37°C
on DNase agar (Scharlau, Barcelona, Spain), and pouring
an excess (~15 ml) of 1 N HCl. Excess acid was
removed with a vacuum pipette and clear zones around
the bacterial colonies indicated DNase positive colonies.
For tube coagulase tests, colonies of test isolates were
re-suspended in 2 ml of citrated sheep or human plasma
in sterile glass test-tubes. Since citrate is utilized by
enterococci [16], pure colonies of Gram positive, Cata-
lase positive staphylococci (catalase tests preceded coa-
gulase reactions) were used. Positive control tubes with
citrated plasma and coagulase producing strain of
S. aureus ATCC 25923 (which efficiently coagulates
citrated plasma) were included. To rule out citrate utili-
zation by other microorganisms, control TCTs contain-
ing citrated plasma with Staphylococcus epidermidis
ATCC 12228 were included. In addition, negative con-
trol tubes containing citrated plasma alone (with no cul-
tures inoculated) were included. The tubes were
incubated at 35°C for 4 hours and observed for clot for-
mation. Where clotting did not occur, the tubes were
incubated at room temperature for an additional 18
hours [9]. Tubes were studied without agitation in order
not to disrupt partially formed clots.
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PCR-amplification of the nuc gene was used as a baseline
test. Reaction mixes were done in a Cleanspot ultraviolet
workstation (COV Lab products, Michigan, USA). The
reactions contained 20 pmoles each of the nuc forward
and reverse primers (5′-GCGATTGATGGTGATA
CGGTT-3′ and 5′-AGCCAAGCCTTGACGAACTA
AAGC-3′, respectively, synthesized by Eurofins-MWG-
Operon, Ebersberg, Germany), 1.5 units of Taq DNA
polymerase (Thermo-Fisher, Surry, UK) and 1 μlo fc u s -
tom PCR master mix (ThermoFisher, Surry, UK). In the
post-amplification room, ~100 ng of staphylococcal chro-
mosomal DNA was added to the reactions as template.
Amplifications were done in a Peltier thermocycler (MJ
Research, Waterman, MA, USA) under the following
conditions: initial denaturation at 94°C, 5 min, followed
by 37 cycles each consisting of a denaturation at 94°C,
1 min; primer annealing at 55°C, 0.5 min, and extension
at 72°C, 1 min; followed by a final extension at 72°C,
7 minutes. After this, the amplicons were mixed with 5 μl
of DNA loading buffer and electrophoresed in a 1% agar-
ose gel in TAE buffer (Tris, acetate and EDTA). Control
reactions included templates of Staphylococcus aureus
ATCC 25923 (positive control), Staphylococcus epidermi-
dis ATCC 12228 and nuclease free water (negative
controls).
Quality control
To minimize cross contamination, standard microbiolo-
gical procedures were strictly followed. Positive and
negative controls were always included in the test reac-
tions. DNA extraction and PCR-amplifications were
done in molecular laboratories that are separate from
the clinical microbiology laboratory where cultures were
grown. The PCR laboratory has designated sections for
pre-amplification, amplification and post-amplification,
with a unidirectional movement of staff.
Data analysis
The data were analyzed using a 2 × 2 contingency table for
diagnostic specificity and sensitivity (table 1). Diagnostic
sensitivities and specificities were calculated as follows:
Sensitivity (%) = [True positive/(True Positive + False
Positive)] × 100
Specificity (%) = [True Negative/(True Negative +
False Negative)] × 100
The positive predictive value (PPV) (%) = [True Posi-
tive/(True Positive + False Positive)] × 100
T h en e g a t i v ep r e d i c t i v ev a l u e( N P V )( % )=[ T r u e
Negative/(True Negative + False Negative)] × 100.
Results and discussion
C o a g u l a s et e s t i n gi st h es i n g l em o s tr e l i a b l em e t h o df o r
identifying Staphylococcus aureus [9]. Coagulase
production can be detected using either the slide coagu-
lase test (SCT) or the tube coagulase test (TCT). Slide
coagulase detects bound coagulase (also called “clump-
ing factor”) [9], which reacts directly with fibrinogen in
plasma, causing rapid cell agglutination. Negative iso-
lates following SCT require confirmation with the
superior TCT, since strains deficient in clumping factor
usually produce free coagulase. Tube coagulase detects
secreted extracellular free coagulase that reacts with a
substance in plasma called “Coagulase-Reacting Factor”
(CRF) to form a complex, which in turn reacts with
fibrinogen to form fibrin (the clot) [9]. Strains of coagu-
lase-positive-animal staphylococci have been isolated
from human clinical specimens, yet some animal staphy-
lococcal isolates also ferment mannitol [13]. This study
evaluated the performance of TCTs, DNase and MSA,
the phenotypic methods commonly used in the identifi-
cation of Staphylococcus aureus.
Detection of Staphylococcus aureus with the available
phenotypic tests
PCR-amplification of the nuc gene, which was used as a
baseline test, detected 32 Staphylococcus aureus of the
60 staphylococcal isolates, see table 2. Of the 32 nuc-
positive Staphylococcus aureus isolates, MSA detected
the highest number of isolates (30 of 32, 94%) while the
TCT (human and sheep plasma respectively) detected
29 and 27 of the 32 isolates (91% and 84% respectively),
table 2. DNase detected the least number of isolates
(24 of 32, 75%).
Nine of the 32 nuc-positive Staphylococcus aureus iso-
lates (28%) were coagulase negative, implying that some
isolates may be misidentified by the TCT as a sole test.
The coagulase negative Staphylococcus aureus may prob-
ably be MRSA isolates which are reported to react weakly
Table 1 Deriving Sensitivity, Specificity, Positive/Negative
Predictive Values for the common identification tests for
S. aureus
Test
results
Staphylococcus
aureus
Other
staphylococci
Total
Positive a b a + b
Negative c d c + d
Total a + c b + d (a + b) + (c + d)
=n
Where,
a = True positives
b = False positives
c = False negatives
d = True negatives
Diagnostic sensitivity = d/(b + d)
Diagnostic specificity = a/(a + c)
Positive predictive value (PPV) = a/(a + b)
Negative predictive value (NPV) = d/(d + c)
n=6 0
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eus strains that are reported to be coagulase negative [9].
Two Staphylococcus aureus isolates (6%) were also MSA
negative. Shittu et al also reported mannitol negative Sta-
phylococcus aureus that was methicillin resistant [15].
Furthermore, eight of the 32 nuc-positive Staphylococcus
aureus isolates were DNase negative (25%). Rao et al
reported DNase negative Staphylococcus aureus but with
no explanation for these findings [18]. Six staphylococci
other than the nuc-confirmed Staphylococcus aureus iso-
lates produced yellow colonies on MSA, and similar find-
ings were reported by other investigators [19-24].
Another rare finding in this study was an isolate that was
D N a s ep o s i t i v eb u tM S A - n e g a t i v ea n dt u b ec o a g u l a s e -
negative (i.e. non-Staphylococcus aureus). We presume
this isolate could have been Staphylococcus schleiferi
subsp. coagulans, which according to the National Stan-
dard Method is also DNase positive [9].
Single phenotypic tests are inefficient for the
identification of Staphylococcus aureus
We used sensitivity and specificity to evaluate the per-
formance of individual tests in detecting Staphylococcus
aureus. Growth on MSA was the most sensitive (94%
sensitivity), followed by the TCT (human and sheep
plasma, 91% and 81% sensitivity respectively) while the
DNase test was the least sensitive (75% sensitivity). Con-
versely, the DNase test was the most specific (96% speci-
ficity) followed by MSA (79% specificity), while the TCT
(human plasma and sheep plasma) was the least specific
(11% and 7%, respectively), table 3. Overall, of the indi-
vidual tests studied, growth on MSA was the best at
identifying Staphylococcus aureus (94% sensitivity and
79% specificity). Our results slightly differ from those of
Han et al, who reported sensitivity and specificity of
76.5% and 99.6%, respectively, for MSA [25]. D’Souza
et al, also reported sensitivity of 71%, a little lower than
ours [26]. The high sensitivity of MSA in detecting Sta-
phylococcus aureus could be due to its ability to isolate
pathogenic Staphylococcus aureus [27], differentiating
coagulase negative staphylococci from coagulase positive
staphylococci.
For tube coagulase, human plasma was more sensitive
than sheep plasma (91% vs. 81% sensitivity), implying
that using sheep plasma with TCTs may detect more
false negative isolates. Thus, in this setting, it is unlikely
Table 2 Identification of S. aureus with the common tests in comparison to PCR-detection of the nuc gene
Other tests nuc PCR
Outcome Positive (% of 32) Negative (% of 28) Subtotal
MSA Positive 30 (94) 6 (21) 36
Negative 2 (6) 22 (79) 24
DNase Positive 24 (75) 1 (4) 25
Negative 8 (25) 27 (96) 35
1Human plasma Positive 29 (91) 25 (89) 54
Negative 3 (9) 3 (11) 6
Human plasma/MSA Positive 27 (84) 6 (21) 31
Negative 0 3 (11) 3
Human plasma/DNase Positive 21 (60) 1 (4) 22
Negative 0 3 (11) 3
Human plasma/MSA/DNase Positive 21 (60) 1 (4) 22
Negative 0 3 (11) 3
2Sheep plasma Positive 26 (81) 26 (93) 52
Negative 6 (19) 2 (8) 8
Sheep plasma/MSA Positive 24 (75) 6 (21) 30
Negative 0 2 (8) 2
Sheep plasma/DNase Positive 18 (56) 1 (4) 19
Negative 0 1 (4) 1
Sheep plasma/MSA/DNase Positive 18 (56) 1 (4) 19
Negative 0 2 (8) 2
MSA/DNase Positive 24 (74) 1 (4) 25
Negative 2 (6) 22 (79) 24
1: tube coagulase (human plasma)
2: tube coagulase (sheep plasma)
MSA: Mannitol salt agar
DNase: Deoxyribonuclease
PCR: Polymerase Chain Reaction
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TCTs. Our data is in agreement with previous findings
in which sensitivity of 94-100% was reported by other
investigators [28-30]. However, in this study, the sensi-
tivity for human and sheep plasma was higher than
what was reported in other settings, where values as low
as 54.5% (human plasma) and 45.5% (sheep plasma)
were reported [28]. Therefore, with coagulase tests,
plasma performance varies with setting and the choice
of plasma can influence the efficiency of the test. Also,
the use of EDTA or citrate as anticoagulant influences
the performance of the test. Noteworthy, citrate only
affects coagulase reactions of enterococci where it is uti-
lized [16], but does not affect coagulase producing
organisms such as Staphylococcus aureus [16].
The DNase test had a sensitivity of 75% and a specifi-
city of 96%, which are comparable to other studies in
which a sensitivity of 75% and a specificity of 100% were
reported [31]. In this study, the DNase test was the
most specific of all tests and had the least number of
false positive isolates (there was only one false positive).
This was in agreement with other reports, in which the
DNase test was reported as superior to the TCT [28,31].
Growth on MSA was also highly specific (79% specifi-
city), while the least specific test was the tube coagulase
(human and sheep plasma, 11% and 7% specificity,
respectively).
In contrast, other studies reported high specificity
(93.6%) for human and sheep plasma with TCTs [32].
The low specificity in our study may partly be due to
the non specific detection of other coagulase positive
staphylococci, such as Staphylococcus schleiferi subspe-
cies coagulans, Staphylococcus delphini, Staphylococcus
intermedius and Staphylococcus hyicus. Staphylococcus
delphini and Staphylococcus intermedius are rare clinical
isolates while Staphylococcus hyicus is indeterminate
(with prevalence ranging from 11% to 89% [17]). The
prevalence of these isolates may be high in certain set-
tings. Although MSA and DNase had high specificities
and sensitivities, as individual tests, their use in routine
identification of Staphylococcus aureus is curtailed by
their ability to detect other bacterial isolates [14], and
are mostly used during initial screens [6]. Indeed, Man-
nitol salt positive CoNS (Staphylococcus caprae,
S. hemolyticus and S. saprophyticus) have been reported
in Nigeria and Japan [13,14]. Thus, in certain settings, if
used individually to identify Staphylococcus aureus,
common phenotypic tests may be insufficient; some iso-
lates will be misidentified, either as Staphylococcus aur-
eus or CoNS.
A combination of MSA and DNase improves the tube
coagulase test
We then evaluated the sensitivity and specificity of test
combinations (i.e. MSA/DNase/TCT) at detecting Sta-
phylococcus aureus, aiming at improving the perfor-
mance of the TCT. We achieved absolute specificity
(100%) in detecting Staphylococcus aureus with test
combinations, with the exception of the DNase/MSA
combination (92% specificity). Conversely, the sensitivity
of test combinations varied, with the MSA/DNase/TCT
(human plasma) being the most sensitive (75% sensitiv-
ity), while MSA/DNase/TCT (sheep plasma) was the
least sensitive (25% sensitivity), table 3.
A combination of MSA/DNase resulted in specificity
and sensitivity of 92% and 96%, respectively, and this
would be the combination of choice for identification of
Staphylococcus aureus. However, since both tests are
not specific to Staphylococcus aureus and can detect
other bacterial isolates, the dual combination can only
be used to improve the TCT. Although other test com-
binations-MSA/DNase/TCT (human plasma) and MSA/
TCT (human plasma) had specificity of 100%, they had
varying sensitivity (75% and 33%, respectively). In this
line, a combination of MSA/DNase/TCT (human
plasma) is better at identifying Staphylococcus aureus
(100% specificity, 75% sensitivity) than the MSA/TCT
(human plasma) combination (100% specificity, 33% sen-
sitivity). Likewise, the DNase/TCT (sheep plasma) and
MSA/TCT (sheep plasma) and MSA/DNase/TCT
(sheep plasma) combinations had an absolute specificity
(100%) but with varying sensitivity (50%, 25% and 67%,
respectively).
Thus, the efficiency of the tube coagulase can be
improved through simultaneous testing that includes
Table 3 Sensitivity, Specificity, Negative/Positive
Predictive values for the common diagnostic tests for
clinical S. aureus
Test Sensitivity
(%)
Specificity
(%)
NPV
(%)
PPV
(%)
MSA 94 79 92 83
DNase 75 96 77 96
1Human plasma 91 11 33 54
2Sheep plasma 81 7 25 50
MSA/DNase 96 92 92 96
Human plasma/MSA 33 100 100 82
Human plasma/DNase 75 100 100 95
Human plasma/DNase/
MSA
75 100 100 94
Sheep plasma/MSA 25 100 100 80
Sheep plasma/DNase 50 100 100 95
Sheep plasma/MSA/
DNase
67 100 100 95
1: Tube coagulase (human plasma)
2: Tube coagulase (sheep plasma)
MSA: Mannitol salt agar
DNase: Deoxyribonuclease
PCR: Polymerase Chain Reaction
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city, sequel identification of Staphylococcus aureus may
c o m m e n c ew i t hM S A ,D N a s ea n dt h e nT C T .N o t e -
worthy, the improved specificity of the TCT did not sig-
nificantly alter the initially observed high sensitivity. The
u s eo fM S Ap r i o rt oT C T s / D N a s ei sh i g h l yr e c o m -
mended due to the clumping factor negative and tube
coagulase positive staphylococci that are increasingly
being recovered from human infections. These isolates
also produce a heat stable DNase and can be misidenti-
fied as Staphylococcus aureus.H o w e v e r ,t h e s es t r a i n s
can be differentiated from Staphylococcus aureus by
their failure to produce acid from maltose, lactose and
mannitol. Furthermore, rare strains of Staphylococcus
aureus can be coagulase negative [9], yet animal isolates
(S. intermidius, S. hyicus, S. delphini and S. schleiferi
subsp. coagulans) can be tube coagulase positive
[9,33,34]; differentiation of these also requires growth
on MSA.
Predictive values
Growth on MSA had the highest negative predictive
value (NPV) followed by DNase, while tube coagulase
had the lowest NPV (which did not match the high sen-
sitivity initially observed, see table 3). Conversely, test
combinations gave absolute NPVs (100%) with the
exception of DNase/MSA (NPV of 92%), table 3. The
high NPVs of the test combinations, particularly those
involving the TCT reveal that test combinations can be
reliably used in routine identification of Staphylococcus
aureus. DNase had the highest positive predictive value
(PPV), followed by MSA (96% and 83%, respectively).
Conversely, tube coagulase alone resulted in average
PPVs (54% and 50%), see table 3. Interestingly, test com-
binations resulted in high PPVs, with those involving
DNase having the highest PPVs (95%), see table 3. Thus,
as for NPVs, the specificity of the TCT can be improved
by a simultaneous identification of the isolates with
DNase and MSA.
Therefore, the ideal identification of Staphylococcus
aureus clinical isolates requires a battery of tests. Sta-
phylococcus aureus infections are more frequent than
those by other bacteria, particularly in settings with high
HIV/AIDS prevalence [35-37]. This warrants correct
identification of the isolates to achieve better treatment
outcomes. Since options for improving the sensitivity
and specificity are presented, these data will improve on
the identification of Staphylococcal aureus in clinical
specimens.
Recommendations
For routine identification of Staphylococcus aureus from
clinical specimens, we recommend simultaneous use of
all the three tests (beginning with growth on MSA,
DNase and Tube coagulase) in settings where rabbit or
horse plasmas are not readily available. Screening of
plasmas from other species (such as rabbit, goat, pig,
and bovine), which can be cheaper and safer, and
reported to be more efficient than human plasma with
TCTs, is recommended. In addition, genotyping of clini-
cal staphylococcal isolates is recommended to speciate
CoNS isolates, and to determine the prevalence of rare
Staphylococcus aureus and animal isolates in human
specimens in Uganda.
Conclusions
We have evaluated the performance of common labora-
tory tests used routinely in the identification of Staphy-
lococcus aureus infections in Uganda. The identification
of clinical Staphylococcus aureus still largely relies on
the tube coagulase test, but it requires screening of the
isolates with two additional tests (MSA and DNase)
prior to TCTs, for improved efficiency. There is no sin-
gle phenotypic test (including the tube coagulase test)
that can guarantee reliable results in the identification
of Staphylococcus aureus.
The specificity of sheep plasma was relatively low
(even in combination with MSA/DNase), and may not
be appropriate for the TCT in some settings. Thus,
where rabbit or horse plasmas are unavailable, sheep
plasma may not replace human plasma. Since human
plasma is inappropriate or risky in some settings, the
performance of plasmas from other animal species
should be investigated for a replacement of human
plasma in TCTs.
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